Tyra Biosciences, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Emerging growth company
State of Incorporation DE
Business Address 2656 STATE STREET, CARLSBAD, CA, 92008
Mailing Address 2656 STATE STREET, CARLSBAD, CA, 92008
Phone (619) 728-4760
Fiscal Year End 1231
EIN 831476348
Financial Overview
FY2025
-$86.48M
Net Income
$363.56M
Total Assets
$91.97M
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| 4 Insider stock transaction report | March 17, 2026 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | March 6, 2026 | View on SEC |
| 8-K Current report of material events | March 4, 2026 | View on SEC |
| 8-K Current report of material events | March 2, 2026 | View on SEC |
| 10-K Annual financial report | March 2, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 20, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 17, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 13, 2026 | View on SEC |
Annual Reports
10-K March 2, 2026
- Precision oncology company developing new medicines for cancer patients resistant to current targeted treatments.
- Proprietary discovery platform for highly selective small molecule inhibitors, with lead candidate TYRA-200 in Phase 2 for FGFR3-mutated bladder cancer.
Insider Trading
STRONG SELL 3 insiders
7 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.